• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide.

作者信息

Fakhouri Fadi, Teixeira Luis, Delarue Richard, Grünfeld Jean-Pierre, Veyradier Agnès

出版信息

Ann Intern Med. 2004 Feb 17;140(4):314-5. doi: 10.7326/0003-4819-140-4-200402170-00028.

DOI:10.7326/0003-4819-140-4-200402170-00028
PMID:14970167
Abstract
摘要

相似文献

1
Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide.
Ann Intern Med. 2004 Feb 17;140(4):314-5. doi: 10.7326/0003-4819-140-4-200402170-00028.
2
Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community.
Ann Intern Med. 2003 Jan 21;138(2):152-3. doi: 10.7326/0003-4819-138-2-200301210-00018.
3
Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura.患者摘要。难治性血栓性血小板减少性紫癜的治疗。
Ann Intern Med. 2003 Jan 21;138(2):I38. doi: 10.7326/0003-4819-138-2-200301210-00004.
4
Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.环磷酰胺和利妥昔单抗治疗后慢性血栓性血小板减少性紫癜的缓解
Ann Intern Med. 2003 Jan 21;138(2):105-8. doi: 10.7326/0003-4819-138-2-200301210-00011.
5
Rituximab for TTP.利妥昔单抗治疗血栓性血小板减少性紫癜
Am J Hematol. 2005 Sep;80(1):87-8. doi: 10.1002/ajh.20364.
6
Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.采用血浆输注联合利妥昔单抗治疗获得性血栓性血小板减少性紫癜（TTP）。
Thromb Haemost. 2008 Jul;100(1):151-3. doi: 10.1160/TH08-02-0089.
7
Treatment of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的治疗
Intensive Care Med. 2005 Apr;31(4):600. doi: 10.1007/s00134-005-2565-9. Epub 2005 Feb 10.
8
Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.利妥昔单抗治疗系统性红斑狼疮合并血栓性血小板减少性紫癜
Lupus. 2008 Jan;17(1):69-71. doi: 10.1177/0961203307083479.
9
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.利妥昔单抗治疗和预防ADAMTS13缺乏型血栓性血小板减少性紫癜的疗效：11例病例研究
Blood. 2005 Sep 15;106(6):1932-7. doi: 10.1182/blood-2005-03-0848. Epub 2005 Jun 2.
10
Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.利妥昔单抗使一名难治性复发性血栓性血小板减少性紫癜患者获得长期缓解。
Int J Hematol. 2005 Jun;81(5):433-6. doi: 10.1532/ijh97.04187.

引用本文的文献

1
Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.关于血栓性血小板减少性紫癜患者 ICU 管理的专家声明。
Intensive Care Med. 2019 Nov;45(11):1518-1539. doi: 10.1007/s00134-019-05736-5. Epub 2019 Oct 7.
2
An improbable and unusual case of thrombotic thrombocytopenia purpura.一例罕见且不寻常的血栓性血小板减少性紫癜病例。
J Community Hosp Intern Med Perspect. 2016 Sep 7;6(4):32258. doi: 10.3402/jchimp.v6.32258. eCollection 2016.
3
Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy.
采用血浆置换、利妥昔单抗、环磷酰胺和脾切除术序贯治疗伴有持续ADAMTS13抑制活性的特发性复发性血栓性血小板减少性紫癜。
Case Rep Oncol. 2015 Apr 22;8(1):196-9. doi: 10.1159/000381868. eCollection 2015 Jan-Apr.
4
Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.获得功能的 ADAMTS13 变异体，对获得性血栓性血小板减少性紫癜患者针对 ADAMTS13 的自身抗体具有抗性。
Blood. 2012 Apr 19;119(16):3836-43. doi: 10.1182/blood-2011-12-399501. Epub 2012 Jan 30.
5
Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.新型重组糖基磷脂酰肌醇（GPI）锚定 ADAMTS13 及其变体用于评估血栓性血小板减少性紫癜患者的抗 ADAMTS13 自身抗体。
Thromb Haemost. 2011 Nov;106(5):947-58. doi: 10.1160/TH11-05-0337. Epub 2011 Sep 8.
6
Why Do We Need ADAMTS13?我们为什么需要ADAMTS13？
Nihon Kessen Shiketsu Gakkai shi. 2005;16(1):54-69. doi: 10.2491/jjsth.16.54.
7
Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.ADAMTS13的分子生物学以及ADAMTS13蛋白水解活性和抑制剂检测的诊断效用
Semin Thromb Hemost. 2005 Dec;31(6):659-72. doi: 10.1055/s-2005-925472.